全文获取类型
收费全文 | 10877篇 |
免费 | 670篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 177篇 |
儿科学 | 322篇 |
妇产科学 | 264篇 |
基础医学 | 1520篇 |
口腔科学 | 662篇 |
临床医学 | 1072篇 |
内科学 | 2005篇 |
皮肤病学 | 353篇 |
神经病学 | 966篇 |
特种医学 | 187篇 |
外科学 | 920篇 |
综合类 | 46篇 |
现状与发展 | 1篇 |
一般理论 | 9篇 |
预防医学 | 1372篇 |
眼科学 | 133篇 |
药学 | 765篇 |
中国医学 | 71篇 |
肿瘤学 | 754篇 |
出版年
2023年 | 92篇 |
2022年 | 67篇 |
2021年 | 315篇 |
2020年 | 199篇 |
2019年 | 321篇 |
2018年 | 330篇 |
2017年 | 239篇 |
2016年 | 328篇 |
2015年 | 372篇 |
2014年 | 455篇 |
2013年 | 615篇 |
2012年 | 937篇 |
2011年 | 1090篇 |
2010年 | 546篇 |
2009年 | 455篇 |
2008年 | 719篇 |
2007年 | 817篇 |
2006年 | 747篇 |
2005年 | 690篇 |
2004年 | 593篇 |
2003年 | 503篇 |
2002年 | 460篇 |
2001年 | 80篇 |
2000年 | 58篇 |
1999年 | 60篇 |
1998年 | 52篇 |
1997年 | 48篇 |
1996年 | 30篇 |
1995年 | 42篇 |
1994年 | 37篇 |
1993年 | 37篇 |
1992年 | 18篇 |
1991年 | 20篇 |
1990年 | 16篇 |
1989年 | 19篇 |
1988年 | 12篇 |
1987年 | 21篇 |
1986年 | 19篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 20篇 |
1982年 | 12篇 |
1981年 | 16篇 |
1980年 | 9篇 |
1979年 | 14篇 |
1976年 | 4篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1972年 | 5篇 |
1971年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
Maria Carolyna Fonseca Batista Arbex Jane Erika Frazão Okazaki Daniela Regina Brandão Tavares Ana Laura Figueiredo Bersani Fania Cristina Santos 《Journal of orthopaedic science》2021,26(1):162-166
BackgroundIn 2007, the Japanese Orthopedic Association established the term “Locomotive Syndrome” (LS) for the concept of locomotor organ dysfunction with potential loss of independence. The purpose of this study was to identify characteristics of LS and establish a diagnostic cut-off for the Geriatric Locomotive Function Scale (GLFS 25-p) for the Brazilian population.MethodsA cross-sectional observational study of the LOCOMOV Project cohort of independent outpatients aged ≥80 years was conducted. Questionnaires on functional status in Basic and Instrumental Activities of Daily Living (Katz and Lawton, respectively) and quality of life (WHOQOL-Bref) were applied, together with the Geriatric Locomotive Function Scale (GLFS 25-p) to identify individuals with LS. Mobility was assessed using the five-times sit-to-stand test, 4-m gait speed, two-step test, one-leg standing time with eyes open and hand-grip test. The data were analyzed using Student's t-test, the Chi–Square test, and multiple logistic regression (stepwise). The significance level was set at 0.05 (5%).ResultsA sample of 102 individuals with mean age of 87.3 (±4.2) years and predominantly female (73.5%) was assessed. We determined a cut-off score of 19 (sensitivity of 0.86 and specificity of 0.67) for diagnosis of LS, as assessed by the GLFS 25-p, and a high prevalence (55%) of the syndrome was found in the sample. In the multiple regression analysis, LS was directly associated with chronic pain (OR 22.24, 95%CI 3.13–157.87), use of a walking device (OR 17.121, 95%CI 1.94–150.49), and inversely associated with gait speed ≥0.8 m/s (OR 0.42, 95%CI 0.006–0.278), perception of good health (OR 0.153, 95%CI 0.029–0.799) and male gender (OR 0.086, 95%CI 0.0105–0.714).ConclusionThe LS in the oldest old proved a very common condition in this survey, especially in women, and was strongly associated with chronic pain, worse performance on physical tests and poor quality of life. 相似文献
4.
Mara Buijs Patricia J. Zondervan Daniel M. de Bruin Krijn P. van Lienden Axel Bex Otto M. van Delden 《Urologic oncology》2019,37(3):183.e1-183.e8
Background
Irreversible electroporation (IRE) has the potential to overcome limitations of thermal ablation, enabling small renal mass (SRM) ablation near vital structures.Purpose
To assess feasibility and safety of percutaneous IRE for the treatment of SRMs.Materials and methods
This prospective study is a phase 2 trial (NCT02828709) of IRE for patients with SRMs. Primary endpoints are feasibility and safety. Device- and procedural-adverse events were assessed by Clavien-Dindo and Common Terminology Criteria for Adverse Events version 4.0 grading systems. Technical feasibility was assessed by recording the technical success of the procedures. Technical success was evaluated by performing a CT immediately after ablation where complete tumor coverage and nonenhancement were evaluated. Tumor charcateristics and patient characteristics, procedural and anesthesia details, postprocedural events, and perioperative complications were recorded.Results
Ten SRMs were included with a mean tumor size of 2.2 cm (range 1.1–3.9 cm) were treated with IRE. Renal mass biopsies revealed 7 clear cell and 1 papillary renal cell carcinoma. Two renal mass biopsies were nondiagnostic. The median follow-up was 6 months (range 3–12 months). Technical success was achieved in 9 out of 10 cases. One patient had a grade 3 Clavien-Dindo complication (1/10, 95% Confidence interval (CI) 0.0179–0.4041). Mean anesthesia time was 3.7 hours (range 3–5 hours), mean procedural time was 2.1 hours (range 1 hour 45 minutes–2 hours 30 minutes) and mean ablation time was 50 minutes (range 20 minutes–1 hour 45 minutes). The creatinine preoperative and postoperative (1 week, 3 months, 6 months, and 12 months) did not significantly differ. In total, 8 out of 10 cases did not experience postoperative pain.Conclusion
IRE in SRMs is safe and feasible. Renal function is not affected by IRE and postoperative pain is rare. Anesthesia time and procedural time are a potential concern. 相似文献5.
6.
Janet Crane Jackie Manfredo Elisa Boscolo Mara Coyan Clifford Takemoto Maxim Itkin Denise M. Adams Timothy D. Le Cras 《Pediatric blood & cancer》2020,67(9)
Kaposiform lymphangiomatosis (KLA) is a rare, life‐threatening congenital lymphatic malformation. Diagnosis is often delayed due to complex indistinct symptoms. Blood angiopoietin‐2 (ANG2) levels are elevated in KLA and may be useful as a biomarker to monitor disease status. We report a 7‐year‐old male child with easy bruising, inguinal swelling, and consumptive coagulopathy, diagnosed with KLA. A multimodal treatment regimen of prednisone, sirolimus, vincristine, and adjunctive zoledronate was used. Plasma ANG2 levels were highly elevated at diagnosis but decreased during treatment. The patient showed significant clinical improvement over a 38‐month period and normalization of ANG2 levels correlated with resolution of the coagulopathy. 相似文献
7.
8.
Juhua Luo Xiwei Chen JoAnn E. Manson Aladdin H. Shadyab Jean Wactawski-Wende Mara Vitolins Thomas E. Rohan Ting-Yuan D. Cheng Zhenzhen Zhang Lihong Qi Michael Hendryx 《International journal of cancer. Journal international du cancer》2020,147(1):65-75
Breast cancer has been suggested to potentially have prenatal origins. We examined associations between birth weight, body mass index (BMI) at four-time points over 25 years of adulthood, and risk of postmenopausal breast cancer, with emphasis on whether the association between birth weight and risk of breast cancer was mediated by weight and height changes over the adult life course. Postmenopausal women (n = 70,397) aged 50–79 years without breast cancer at enrollment (1993–1998) were followed up to 25 years. Weight and height were measured at baseline. Birth weight, and weights at ages 18, 35 and 50 were self-reported. Breast cancer cases were centrally adjudicated. Compared to women with birth weight of 6–8 pounds, women with birth weight of <6 pounds had lower risk of breast cancer (HR = 0.88 95% CI: 0.79–0.99). 44% and 21% of the relationship between birth weight and breast cancer risk was mediated by adult height and weight at baseline, respectively. Birth weight of 8 pounds or more was not associated with risk of postmenopausal breast cancer. Weight gain in adulthood was associated with increased risk of breast cancer regardless of time periods. In conclusion, lower birthweight was associated with lower risk of postmenopausal breast cancer, and this reduction in risk was significantly mediated by childhood or adolescent growth, especially by adult height. Our data suggest that reaching and maintaining a healthy weight during adulthood is key in the prevention of breast cancer. 相似文献
9.
In recent years, there has been an increased focus on patient involvement in treatment planning in the health care system. To reduce the risk of the clinician moving towards paternalism, various methods have been introduced—shared decision making, among others. The goal of shared decision making is for the clinician and patient to share available evidence on the best treatment and to raise awareness on the needs and preferences of the patient as to make a genuinely informed choice. However, in the present article, we discuss to which degree paternalism can be avoided in light of the clinician's role as an authority with certain knowledge and expertise. Through the philosophical theory of reasons‐responsiveness, we discuss to which extend free will and control applies to the patient. Through theoretical analysis, we come to suggest that the clinician has a role as an ally rather than manipulator. 相似文献
10.
Jaime Feliu Beatriz Jiménez-Munárriz Laura Basterretxea Irene Paredero Elisenda Llabrés Maite Antonio-Rebollo Beatriz Losada Enrique Espinosa Regina Gironés Ana Belén Custodio María del Mar Muñoz Mariana Díaz-Almirón Jeniffer Gómez-Mediavilla Alvaro Pinto María-Dolores Torregrosa Gema Soler Patricia Cruz Oliver Higuera María José Molina-Garrido 《The oncologist》2020,25(10):e1516-e1524